Difference between revisions of "Profiles"

From QIBA Wiki
Jump to navigation Jump to search
Line 49: Line 49:
*[[Clinical Sites]]
*[[Clinical Sites]]
*[[Additional letters of support can be found here]]
*[[Additional letters of support can be found here]]
==See Also==
==See Also==

Revision as of 16:05, 10 January 2018

Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.

Stage 3: Technically Confirmed Profiles

Stage 2: Consensus Profiles

Stage 1: Public Comment Profiles

--There are currently no Profiles open for Public Comment--

Please submit all public comments through the following online form: http://tinyurl.com/QIBA-Public-Comment-Form
(Note: each form accommodates 10 comments; you may submit additional forms as necessary)

Public Comment closed for the following Profiles (comment resolution is currently underway):

Format for Citing Profiles

Note to users: When referencing QIBA Profile documents, please use the following format:

Specific QIBA Biomarker Committee. * Specific Profile Title, * Quantitative Imaging Biomarkers Alliance. * Version. * Profile Stage. * QIBA, * Date. * Available from: URL

Format example:

QIBA SPECT Biomarker Committee. Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases, Quantitative Imaging Biomarkers Alliance. Version 1.1. Profile Stage: Consensus. QIBA, June 30, 2017. Available from: http://qibawiki.rsna.org/index.php/Profiles

Statements of Endorsement

See Also